Sinco Pharmaceuticals may offer up to HK$170 million of convertibles

By Abigail W. Adams

Portland, Me., Jan. 29 – Sinco Pharmaceuticals Holdings Ltd. is exploring the possibility of issuing up to HK$170 million of convertible bonds, according to a company news release.

Proceeds would be used to refinance existing debt and broaden the company’s capital base.

The possible issuance may not materialize, and no definitive agreement regarding the convertible bonds has been entered into, the company said in a press release.

Sinco Pharmaceuticals is a Chengdu, China-based investment holding company that provides marketing and promotion for imported pharmaceutical products in China.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.